Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 23, 2020
Safe nanoengineering and incorporation of transplant populations in a neurosurgical grade biomaterial, DuraGen Plus<sup>TM</sup>, for protected cell therapy applications
Louise Finch, Sarah Harris, Georgios Solomou, et al.
European Journal of Neurology
|
June 4, 2025
Glial Fibrillary Acidic Protein as a Marker of Disease in Relapsing Multiple Sclerosis: Post Hoc Analysis of Phase 3 Ozanimod Trials
Sarah Harris, Giancarlo Comi, Bruce A C Cree, et al.
Translational Vision Science & Technology
|
August 25, 2020
Quantifiable In Vivo Imaging Biomarkers of Retinal Regeneration by Photoreceptor Cell Transplantation
Ying V Liu, Simrat K Sodhi, Gilbert Xue, et al.
The Journal of Allergy and Clinical Immunology. Global
|
December 26, 2025
Inflammatory and fibrotic biomarkers in patients with atopic dermatitis treated with cendakimab
Jie Li, Coryandar Gilvary, Lu Gao, et al.
Experimental Eye Research
|
August 3, 2021
Characterization and allogeneic transplantation of a novel transgenic cone-rich donor mouse line
Ying V Liu, Derek Teng, Gregory J Konar, et al.
Annals of Clinical and Translational Neurology
|
August 8, 2023
SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosis
Bruce A C Cree, Rachel Maddux, Amit Bar-Or, et al.
Investigational New Drugs
|
January 25, 2014
A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors
Margaret von Mehren, Carolyn D Britten, Peter Pieslor, et al.
The British Journal of Dermatology
|
December 11, 2025
Topical Steroid Withdrawal (TSW) Syndrome: Developing Diagnostic Criteria through a Modified Delphi Method
Cynhia Hsu, Lily Guo, Derrick Adams, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Development of an image-guided non-vitrectomy subretinal access approach for trans-scleral cell and gene therapy delivery
Mandeep S Singh, Shoujing Guo, Christopher B Toomey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemia
John C Byrd, Susan O'Brien, Ian W Flinn, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 23, 2020
Safe nanoengineering and incorporation of transplant populations in a neurosurgical grade biomaterial, DuraGen Plus<sup>TM</sup>, for protected cell therapy applications
Louise Finch, Sarah Harris, Georgios Solomou, et al.
European Journal of Neurology
|
June 4, 2025
Glial Fibrillary Acidic Protein as a Marker of Disease in Relapsing Multiple Sclerosis: Post Hoc Analysis of Phase 3 Ozanimod Trials
Sarah Harris, Giancarlo Comi, Bruce A C Cree, et al.
Translational Vision Science & Technology
|
August 25, 2020
Quantifiable In Vivo Imaging Biomarkers of Retinal Regeneration by Photoreceptor Cell Transplantation
Ying V Liu, Simrat K Sodhi, Gilbert Xue, et al.
The Journal of Allergy and Clinical Immunology. Global
|
December 26, 2025
Inflammatory and fibrotic biomarkers in patients with atopic dermatitis treated with cendakimab
Jie Li, Coryandar Gilvary, Lu Gao, et al.
Experimental Eye Research
|
August 3, 2021
Characterization and allogeneic transplantation of a novel transgenic cone-rich donor mouse line
Ying V Liu, Derek Teng, Gregory J Konar, et al.
Annals of Clinical and Translational Neurology
|
August 8, 2023
SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosis
Bruce A C Cree, Rachel Maddux, Amit Bar-Or, et al.
Investigational New Drugs
|
January 25, 2014
A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors
Margaret von Mehren, Carolyn D Britten, Peter Pieslor, et al.
The British Journal of Dermatology
|
December 11, 2025
Topical Steroid Withdrawal (TSW) Syndrome: Developing Diagnostic Criteria through a Modified Delphi Method
Cynhia Hsu, Lily Guo, Derrick Adams, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Development of an image-guided non-vitrectomy subretinal access approach for trans-scleral cell and gene therapy delivery
Mandeep S Singh, Shoujing Guo, Christopher B Toomey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemia
John C Byrd, Susan O'Brien, Ian W Flinn, et al.
Page
of 12